Martine A. Rothblatt
Chairperson & CEO
Common Stock
- Value context
- $1.12M
- Reported price
- $117.76 / share
UNITED THERAPEUTICS Corp
Last 30 daysNo qualifying insider buying. Sales: $114.49M by 3 insiders.
Showing the first 6 of 20 trades on this page.
Chairperson & CEO
Common Stock
Chairperson & CEO
Stock Option
Derivative security · not the ordinary share price.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chairperson & CEO
Common Stock
Chairperson & CEO
Stock Option
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chairperson & CEO
Common Stock
Chairperson & CEO
Stock Option
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chairperson & CEO
Common Stock
Chairperson & CEO
Stock Option
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP & GENERAL COUNSEL
Common Stock
EVP & GENERAL COUNSEL
Stock Option
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chairperson & CEO
Common Stock
Chairperson & CEO
Stock Option
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chairperson & CEO
Common Stock
Chairperson & CEO
Stock Option
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chairperson & CEO
Common Stock
Chairperson & CEO
Stock Option
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chairperson & CEO
Common Stock
Chairperson & CEO
Stock Option
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chairperson & CEO
Common Stock
Chairperson & CEO
Stock Option
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chairperson & CEO | Common StockOption exercise or conversion10b5-1 | 9,500$117.76 / share | $1.12M | Oct 6Filed Oct 7 · 1d later | SEC filing |
| Chairperson & CEO | Stock OptionOption exercise or conversion10b5-1 | Derivative units9,500$117.76 exercise / conversion price | Not a separate purchase | Oct 6Filed Oct 7 · 1d later | SEC filing |
| Chairperson & CEO | Common StockOption exercise or conversion10b5-1 | 9,500$117.76 / share | $1.12M | Oct 5Filed Oct 6 · 1d later | SEC filing |
| Chairperson & CEO | Stock OptionOption exercise or conversion10b5-1 | Derivative units9,500$117.76 exercise / conversion price | Not a separate purchase | Oct 5Filed Oct 6 · 1d later | SEC filing |
| Chairperson & CEO | Common StockOption exercise or conversion10b5-1 | 9,500$117.76 / share | $1.12M | Oct 2Filed Oct 5 · 3d later | SEC filing |
| Chairperson & CEO | Stock OptionOption exercise or conversion10b5-1 | Derivative units9,500$117.76 exercise / conversion price | Not a separate purchase | Oct 2Filed Oct 5 · 3d later | SEC filing |
| Chairperson & CEO | Common StockOption exercise or conversion10b5-1 | 9,500$117.76 / share | $1.12M | Oct 1Filed Oct 2 · 1d later | SEC filing |
| Chairperson & CEO | Stock OptionOption exercise or conversion10b5-1 | Derivative units9,500$117.76 exercise / conversion price | Not a separate purchase | Oct 1Filed Oct 2 · 1d later | SEC filing |
| EVP & GENERAL COUNSEL | Common StockOption exercise or conversion10b5-1 | 8,300$146.03 / share | $1.21M | Oct 1Filed Oct 1 · 0d later | SEC filing |
| EVP & GENERAL COUNSEL | Stock OptionOption exercise or conversion10b5-1 | Derivative units8,300$146.03 exercise / conversion price | Not a separate purchase | Oct 1Filed Oct 1 · 0d later | SEC filing |
| Chairperson & CEO | Common StockOption exercise or conversion10b5-1 | 9,500$117.76 / share | $1.12M | Sep 30Filed Oct 1 · 1d later | SEC filing |
| Chairperson & CEO | Stock OptionOption exercise or conversion10b5-1 | Derivative units9,500$117.76 exercise / conversion price | Not a separate purchase | Sep 30Filed Oct 1 · 1d later | SEC filing |
| Chairperson & CEO | Common StockOption exercise or conversion10b5-1 | 9,500$117.76 / share | $1.12M | Sep 29Filed Sep 30 · 1d later | SEC filing |
| Chairperson & CEO | Stock OptionOption exercise or conversion10b5-1 | Derivative units9,500$117.76 exercise / conversion price | Not a separate purchase | Sep 29Filed Sep 30 · 1d later | SEC filing |
| Chairperson & CEO | Common StockOption exercise or conversion10b5-1 | 9,500$117.76 / share | $1.12M | Sep 28Filed Sep 29 · 1d later | SEC filing |
| Chairperson & CEO | Stock OptionOption exercise or conversion10b5-1 | Derivative units9,500$117.76 exercise / conversion price | Not a separate purchase | Sep 28Filed Sep 29 · 1d later | SEC filing |
| Chairperson & CEO | Common StockOption exercise or conversion10b5-1 | 9,500$117.76 / share | $1.12M | Sep 25Filed Sep 28 · 3d later | SEC filing |
| Chairperson & CEO | Stock OptionOption exercise or conversion10b5-1 | Derivative units9,500$117.76 exercise / conversion price | Not a separate purchase | Sep 25Filed Sep 28 · 3d later | SEC filing |
| Chairperson & CEO | Common StockOption exercise or conversion10b5-1 | 9,500$117.76 / share | $1.12M | Sep 24Filed Sep 25 · 1d later | SEC filing |
| Chairperson & CEO | Stock OptionOption exercise or conversion10b5-1 | Derivative units9,500$117.76 exercise / conversion price | Not a separate purchase | Sep 24Filed Sep 25 · 1d later | SEC filing |
Showing the latest 20 of 412 trades. Show all 412 trades
United Therapeutics Corporation - Common Stock (UTHR) · Stock
The filing reports a sale for a spouse.
Lisa McClainReporting House memberUnited Therapeutics Corporation - Common Stock (UTHR) · Stock
The filing reports a purchase for a spouse.
Lisa McClainReporting House memberUnited Therapeutics Corporation - Common Stock (UTHR) · Stock
The filing reports a sale for a spouse.
Lisa McClainReporting House member